Here's the live share price of Unjha Formulations along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Unjha Formulations has gained 25.84% CAGR. Over the past year, the corresponding return has been -19.23%.
Unjha Formulations’s current P/E of 115.69x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Unjha Formulations | -0.2 | 1.26 | 4.12 | 17.71 | -19.23 | 40.55 | 25.84 |
Sun Pharmaceutical Industries | 0.94 | -1.45 | -2.44 | -5.71 | -13.78 | 22.53 | 25.74 |
Divi's Laboratories | 1.54 | -0.7 | -6.33 | 8 | 12.26 | 19.15 | 13.78 |
Cipla | -0.82 | -0.86 | 3.16 | 3.88 | -7.19 | 14.44 | 15.58 |
Torrent Pharmaceuticals | -1.87 | -3.48 | 8.42 | 15.22 | 2.15 | 33.58 | 19.96 |
Dr. Reddy's Laboratories | 0.29 | 3.49 | -0.83 | 13.69 | -1.37 | 16.85 | 6.26 |
Mankind Pharma | -1.22 | 4.33 | 9.55 | 18.64 | 5.03 | 21.86 | 12.59 |
Zydus Lifesciences | -0.82 | 4.49 | 7.5 | 15.4 | -7.16 | 42.04 | 21.2 |
Lupin | 3 | 3.43 | 4.81 | 2.31 | -10.29 | 46.98 | 14.44 |
Abbott India | -0.31 | -4.38 | -1.9 | 3.41 | 8.06 | 21.52 | 13.67 |
Alkem Laboratories | 2.88 | 2.34 | 13.74 | 13.65 | -11.99 | 19.03 | 14.03 |
Aurobindo Pharma | 4.38 | 0.59 | -1.18 | -1.48 | -29.36 | 28.25 | 6.21 |
Glenmark Pharmaceuticals | -3.73 | 3.93 | 24.08 | 43.4 | 19.76 | 76.91 | 33.04 |
Laurus Labs | 0.42 | 4.06 | 36.31 | 54.86 | 79.62 | 21.06 | 26.22 |
Biocon | -0.99 | -1.06 | 2.21 | 7.92 | -4.03 | 7.5 | -4.01 |
Anthem Biosciences | 2.58 | 4.46 | 14.53 | 14.53 | 14.53 | 4.63 | 2.75 |
GlaxoSmithKline Pharmaceuticals | -2.62 | -1.08 | -15.16 | 2.48 | -1.45 | 25.05 | 9.38 |
Cohance Lifesciences | -0.3 | 9.77 | -0.58 | -13.11 | -14.61 | 28.98 | 20.79 |
Ipca Laboratories | 0.68 | -4.46 | -2.5 | 0.56 | -9.17 | 15.55 | 4.26 |
Gland Pharma | 5.08 | 1.44 | 14.5 | 28.77 | 8.28 | -3.78 | 1.9 |
Over the last one year, Unjha Formulations has declined 19.23% compared to peers like Sun Pharmaceutical Industries (-13.78%), Divi's Laboratories (12.26%), Cipla (-7.19%). From a 5 year perspective, Unjha Formulations has outperformed peers relative to Sun Pharmaceutical Industries (25.74%) and Divi's Laboratories (13.78%).
Day | SMA | EMA |
---|---|---|
5 | 25.08 | 25.1 |
10 | 25.04 | 25.06 |
20 | 24.99 | 24.98 |
50 | 24.72 | 24.69 |
100 | 24.09 | 24.58 |
200 | 25.42 | 24.78 |
In the latest quarter, Unjha Formulations remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 63.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 05, 2025, 8:10 PM IST | Unjha Formulatio - Submissions Of XML File For Financial Statement I.E. Balance Sheet , P&L Accounts And Cash Flow Statement |
Aug 14, 2025, 12:42 AM IST | Unjha Formulatio - Filing Of Distribution Schedule |
Aug 14, 2025, 12:32 AM IST | Unjha Formulatio - Cash Flow Statement For The Year Ended 31.03.2025 |
Aug 14, 2025, 12:29 AM IST | Unjha Formulatio - Intimation Under Regulation 30 Read With Part A Of The Schedule III Of SEBI (Listing Obligations And Discl |
Aug 14, 2025, 12:25 AM IST | Unjha Formulatio - Regulation 44(3) Of The SEBI (Listing Obligation And Disclosure Requirements) I.E. Voting Results |
Unjha Formulations Ltd. is a Public Limited Listed company incorporated on 02/09/1994 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L99999GJ1994PLC022932 and registration number is 022932. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 13.86 Cr. and Equity Capital is Rs. 4.48 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Unjha Formulations is ₹24.99 as on Sep 17, 2025.
The Unjha Formulations is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Unjha Formulations is ₹11.20 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Unjha Formulations are ₹25.75 and ₹24.21.
The 52-week high/low is the highest and lowest price at which Unjha Formulations stock has traded in the past 52-week or nearly a year. The 52-week high of Unjha Formulations is ₹39.00 and 52-week low of Unjha Formulations is ₹19.99 as on Sep 17, 2025.
The Unjha Formulations has shown returns of 0.44% over the past day, 1.26% for the past month, 4.12% over 3 months, -19.23% over 1 year, 40.55% across 3 years, and 25.84% over 5 years.
P/E ratio of and PB ratio of Unjha Formulations are 115.69 and 3.57 on Sep 17, 2025. While the company gives a dividend yield of 0.00 per annum.